AL
LGND icon

AJO LP’s Ligand Pharmaceuticals LGND Stock Holding History

AJO LP’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-75,062
Closed -$4.46M – 487
2020
Q3 		$4.46M Buy
+75,062
New +$5.12M 0.05% 276
2020
Q1 		– Sell
-2,568
Closed -$167K – 706
2019
Q4 		$167K Sell
2,568
-309,605
-99% -$20.7M ﹤0.01% 518
2019
Q3 		$19.4M Buy
312,173
+2,671
+0.9% +$168K 0.11% 168
2019
Q2 		$22M Sell
309,502
-36,866
-11% -$2.72M 0.11% 172
2019
Q1 		$27.2M Sell
346,368
-71,938
-17% -$5.45M 0.14% 166
2018
Q4 		$35.4M Sell
418,306
-5,046
-1% -$538K 0.2% 129
2018
Q3 		$72.5M Sell
423,352
-61,283
-13% -$9.24M 0.34% 93
2018
Q2 		$62.6M Sell
484,635
-23,029
-5% -$2.57M 0.29% 108
2018
Q1 		$52.3M Buy
507,664
+322,580
+174% +$31.9M 0.24% 116
2017
Q4 		$15.8M Buy
185,084
+123,960
+203% +$10.7M 0.07% 197
2017
Q3 		$5.19M Buy
61,124
+50,119
+455% +$3.97M 0.02% 312
2017
Q2 		$833K Sell
11,005
-138,502
-93% -$9.69M ﹤0.01% 503
2017
Q1 		$9.87M Buy
149,507
+69,434
+87% +$4.57M 0.04% 213
2016
Q4 		$5.08M Sell
80,073
-116,080
-59% -$7.33M 0.02% 271
2016
Q3 		$12.5M Sell
196,153
-471,570
-71% -$34.6M 0.05% 206
2016
Q2 		$49.7M Sell
667,723
-293,780
-31% -$21.8M 0.22% 109
2016
Q1 		$64.2M Buy
961,503
+659,187
+218% +$40.1M 0.28% 100
2015
Q4 		$20.4M Buy
302,316
+236,487
+359% +$14.6M 0.09% 173
2015
Q3 		$3.52M Buy
65,829
+11,022
+20% +$669K 0.02% 319
2015
Q2 		$3.45M Buy
+54,807
New +$2.99M 0.01% 341

Other funds holding LGND

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

AJO LP's LGND Position: Q4 2020 in Review

AJO LP sold out of Ligand Pharmaceuticals (LGND) in Q4 2020, closing a stake of 75,062 shares — an estimated $4.46M sold.

AJO LP first reported a position in LGND in Q2 2015 and held it in 20 quarters. The position peaked at $72.5M in Q3 2018. 242 funds tracked by Wall St. Rank hold LGND as of Q4 2020.

  • AJO LP reported no remaining Ligand Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 75,062 Ligand Pharmaceuticals shares in Q4 2020, an estimated $4.46M.
  • AJO LP first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 20 quarters.
  • AJO LP's Ligand Pharmaceuticals position peaked at $72.5M in Q3 2018.
  • 242 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.